Results 141 to 150 of about 2,203 (155)
Some of the next articles are maybe not open access.
Microbial drug resistance (Larchmont, N.Y.), 2018
Currently, echinocandins are first-line drugs for treatment of invasive candidiasis. However, data on how serum influences killing activity of echinocandins against uncommon Candida species are limited. Therefore, the killing activity of micafungin in RPMI-1640 and in 50% serum was compared against Candida guilliermondii, Candida lusitaniae, and ...
Qasem, Saleh +6 more
openaire +1 more source
Currently, echinocandins are first-line drugs for treatment of invasive candidiasis. However, data on how serum influences killing activity of echinocandins against uncommon Candida species are limited. Therefore, the killing activity of micafungin in RPMI-1640 and in 50% serum was compared against Candida guilliermondii, Candida lusitaniae, and ...
Qasem, Saleh +6 more
openaire +1 more source
Antifungal therapies in murine infections by Candida kefyr
Mycoses, 2016Javier Capilla +2 more
exaly
Systemic candidiasis by Candida kefyr: Case series from Pakistan
Journal of Medical Case Reports and Case Series, 2023openaire +1 more source
Isolation and characterization of Candida kefyr orotidine‐5′‐phosphate decarboxylase (URA3) gene
Yeast, 2010Paul Wai-Kei Tsang
exaly
Bioethanol Production from Cull Dates by <I>Candida kefyr</I>
Journal of Biobased Materials and Bioenergy, 2012Haifa Chtourou +2 more
exaly
Candida kefyr, an Uncommon but Emerging Fungal Pathogen: Report of Two Cases
Pharmacotherapy, 2004exaly